However, the increased intratumoral frequency of the specific fraction of IL-17+ γδT cells indeed seemed to be associated with clinical parameters such as enhanced tumor size, vascular invasion, and lymph node metastasis, thus indicating CRC invasiveness and progression [14]. This evidence concerns the gene IL17A and neoplasm.